OBJECTIVE: To identify patient- and decision-type predictors of two key aspects of informed decision making: discussing the cons (not just the pros) of medical interventions and asking patients what they want to do. METHODS: Using data from 2473 members of the DECISIONS survey, a nationally representative sample of U.S. adults age 40+, we used logistic regression analysis to identify which patient characteristics predicted patient reports of healthcare providers discussing cons or eliciting preferences about one of 9 common medical decisions. RESULTS: Multiple demographic characteristics predicted both discussions of cons and elicitations of preferences, although the specific characteristics varied between decision contexts. In particular, African-American respondents reported being more likely to receive a discussion of the cons of cancer screening (OR=1.69, p<0.05) yet less likely to have been asked their opinion about either getting a cancer screening test (OR=0.56, p<0.05) or initiating medications (OR=0.53, p<0.05). Significant cross-decision variations remained even after controlling for patient characteristics. CONCLUSIONS: Important disparities in patient communication and involvement appear to exist both between different types of medical decisions and between different types of patients. PRACTICE IMPLICATIONS: Providers must make sure to consistently discuss the cons of treatment and to solicit input from all patients, especially African-Americans.
OBJECTIVE: To identify patient- and decision-type predictors of two key aspects of informed decision making: discussing the cons (not just the pros) of medical interventions and asking patients what they want to do. METHODS: Using data from 2473 members of the DECISIONS survey, a nationally representative sample of U.S. adults age 40+, we used logistic regression analysis to identify which patient characteristics predicted patient reports of healthcare providers discussing cons or eliciting preferences about one of 9 common medical decisions. RESULTS: Multiple demographic characteristics predicted both discussions of cons and elicitations of preferences, although the specific characteristics varied between decision contexts. In particular, African-American respondents reported being more likely to receive a discussion of the cons of cancer screening (OR=1.69, p<0.05) yet less likely to have been asked their opinion about either getting a cancer screening test (OR=0.56, p<0.05) or initiating medications (OR=0.53, p<0.05). Significant cross-decision variations remained even after controlling for patient characteristics. CONCLUSIONS: Important disparities in patient communication and involvement appear to exist both between different types of medical decisions and between different types of patients. PRACTICE IMPLICATIONS: Providers must make sure to consistently discuss the cons of treatment and to solicit input from all patients, especially African-Americans.
Authors: Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew Journal: Adv Cancer Res Date: 2019-04-23 Impact factor: 6.242
Authors: Steven H Woolf; Alex H Krist; Jennifer Elston Lafata; Resa M Jones; Rebecca R Lehman; Camille J Hochheimer; Roy T Sabo; Dominick L Frosch; Brian J Zikmund-Fisher; Daniel R Longo Journal: Am J Prev Med Date: 2017-12-11 Impact factor: 5.043
Authors: Chanita Hughes Halbert; Sebastiano Gattoni-Celli; Stephen Savage; Sandip M Prasad; Rick Kittles; Vanessa Briggs; Ernestine Delmoor; LaShanta J Rice; Melanie Jefferson; Jerry C Johnson Journal: Am J Mens Health Date: 2016-07-08
Authors: Laura E Brotzman; Danielle M Crookes; Jessica D Austin; Alfred I Neugut; Rachel C Shelton Journal: Transl Behav Med Date: 2021-10-23 Impact factor: 3.626